ArticleAmino acids2025
MTR4 methylation-dependent degradation activates mTORC1 signaling to promote glioma cell survival under methionine starvation.
Article in Amino acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Methionine is an essential amino acid for the human body. Understanding how tumor cells adjust their signaling networks to evade apoptosis and sustain proliferation in a methionine starvation tumor microenvironment is a significant scientific question that warrants in-depth investigation. This study aims to explore the response mechanisms of glioma under methionine starvation conditions, thereby providing a theoretical foundation for the development of novel therapeutic strategies for glioma. To investigate the response of glioma cells to a methionine starvation environment, we established methionine-starvation-tolerant cells. Our findings indicate that mRNA transporter 4 (MTR4) plays a crucial role in cellular adaptation to methionine starvation. This study employed various experimental approaches, including Western blotting, immunohistochemical staining, and colony formation assays, to validate the expression mechanism of MTR4 under methionine starvation conditions. Furthermore, transfection, quantitative reverse transcription polymerase chain reaction (qRT-PCR), and cytoplasmic-nuclear fractionation techniques were utilized to explore the regulatory mechanism of MTR4 on solute carrier family 1 member 5 (SLC1A5). In response to methionine starvation, glioma cells exhibited a time-dependent activation of the mTOR signaling pathway. Transcriptomic analysis revealed a high expression of the methionine transporter SLC1A5, which is regulated at the mRNA level by the nuclear export factor MTR4. Under conditions of methionine starvation, MTR4 undergoes methylation, leading to its ubiquitination. Lysine Methyltransferase 2B (KMT2B) has been identified as the methyltransferase responsible for the methylation of MTR4. In summary, we propose that under conditions of methionine starvation, the enhanced methylation of MTR4 promotes its ubiquitin-mediated degradation. This process facilitates the nuclear export and expression of amino acid transporter mRNA, such as SLC1A5, leading to increased amino acid uptake, activation of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway, and ultimately ensuring the survival of glioma cells. Our study provides new insights into the molecular mechanisms underlying glioma cell adaptation to methionine starvation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.